Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Prywatna Praktyka Lekarska Prof Dr Hab Med Paweł Hrycaj

Research site

Poland os. Rzeczypospolitej 6/202 Poznań, 61-397 Poznan, Poland

  • Systemic lupus erythematosus · Rheumatoid arthritis
  • Adult patients

About Specializations

Prywatna Praktyka Lekarska Prof Dr Hab Med Paweł Hrycaj in Poznan, Poland specialises in clinical trials of conditions such as Systemic lupus erythematosus, Rheumatoid arthritis, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

The research at Prywatna Praktyka Lekarska Prof Dr Hab Med Paweł Hrycaj concentrates on immune system diseases, with a specific focus on Systemic Lupus Erythematosus in adult patients.

  • Evaluation of a novel biologic targeting type‑I interferon pathways
  • Assessment of a B‑cell modulating antibody for disease activity reduction

The trials are designed to compare new therapeutic agents with placebo, seeking to improve overall disease activity scores for individuals with moderate‑to‑severe Systemic Lupus Erythematosus.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
os. Rzeczypospolitej 6/202 Poznań61-397 PoznanPoland
Open in maps ↗
Recruiting now
no trials
Conditions studied
2

More sites in PoznanPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Dr Reddy's Laboratories Limited

Systemic lupus erythematosus

Not recruiting

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obexelimab
  • Sponsor:Zenas Biopharma (USA) LLC

Systemic lupus erythematosus

Not recruiting

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.